IRMD - Iradimed Corp

NYSE * Health Care * Health Care Equipment & Supplies

$93.05

$-0.51 (-0.55%)

About Iradimed Corp

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible intravenous infusion pump systems and MRI compatible patient vital signs monitoring systems and related accessories. The company offers MRidium 3870 and 3860+ MRI Compatible IV Infusion Pump System with associated disposable IV tubing sets; 3880 MRI compatible patient vital signs monitoring system; and 3600 FMD1 with remote alarm logging unit ferromagnetic detection device. It also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. The company serves hospitals, acute care facilities, and outpatient imaging centers. It sells its products through direct field sales representatives, regional sales directors, clinical application specialists, and independent distributors in the United States and internationally. The company was incorporated in 1992 and is headquartered in Orlando, Florida.

IRMD Key Statistics

Market Cap

$1.20B

P/E Ratio

53.46

P/B Ratio

12.64

EPS

$1.75

Dividend Yield

0.01%

Revenue Growth

+0.2%

Profit Margin

0.3%

Employees

166

How IRMD Compares to Peers

IRMD trades at a premium valuation vs peers (highest P/E)
IRMD has the highest profit margins in Health Care Equipment & Supplies
IRMD has the fastest revenue growth among competitors

P/E Rank

#2

of 2

Margin Rank

#1

of 2

Growth Rank

#1

of 2

Size Rank

#2

of 2

CompanyP/EGrowthCompare
IRMD53.50%-
AMZN34.70%vs AMZN

Iradimed Corp Company Information

Headquarters
Florida; U.S.A
Website
www.iradimed.com
Sector
Health Care
Industry
Health Care Equipment & Supplies
Data Updated:
Ready to invest in IRMD?

Commission-free trading available. Affiliate links.

IRMD Lician Score

10% confidence
6.0/10
Good

IRMD has a Lician Score of 6/10 (Good). Strengths: Growth.

value

5.0

growth

9.0

quality

5.0

momentum

5.0

safety

5.0

The Lician Score is a comprehensive 1-10 rating that evaluates IRMDacross five key dimensions: Value (valuation relative to sector),Growth (revenue and earnings trajectory),Quality (profitability and balance sheet strength),Momentum (price trends and analyst sentiment), andSafety (volatility and risk metrics).

IRMD Financial Snowflake

5-axis analysis across key investment dimensions

5.8/10

Neutral

35810Value5.0Growth9.0Quality5.0Momentum5.0Safety5.05.8/10
5.0

Value

9.0

Growth

5.0

Quality

5.0

Momentum

5.0

Safety

Upcoming Events for IRMD